Evaluating the NFPp10a/NF5310 glioblastoma model as a faithful avatar for screening tumour microenvironment–targeted therapies
Kieron White, James Clerkin, Liam P. Shiels, Kieron Sweeney et autres
Despite positive outcomes for novel targeted therapy screens in preclinical studies, the majority of follow on GBM clinical trials fail to meet their primary endpoints. This translational gap is partly due to models that do not accurately recapitulate the human GBM-TME and …
ie, fr, be, nl (code pays fourni par la source)
0 citations
Communications Biology